Agilent Technologies(US:A)2026-03-03 21:17Revenue Performance - Net revenue for the three months ended January 31, 2026, was $1,798 million, representing a 7% increase compared to the same period last year[134]. - Revenue from products increased by 6% to $1,273 million, while services and other revenue rose by 9% to $525 million for the same period[151]. - Total net revenue for the three months ended January 31, 2026, was $1,798 million, representing a 7% increase compared to $1,681 million in the same period last year[154]. - Revenue growth was driven by all segments and geographic regions, with notable increases in consumables and contract development and manufacturing[152]. - Revenue in the Life Sciences and Diagnostics Markets segment increased by 5% to $679 million, with a 2 percentage point favorable impact from foreign currency movements[170]. - Revenue in the Agilent CrossLab segment rose by 9% to $758 million, benefiting from a 3 percentage point favorable impact from foreign currency movements[155]. - Revenue in the Applied Markets segment increased by 7% to $361 million, with a 3 percentage point favorable impact from foreign currency movements[156]. - Revenue growth in the Americas was 5%, in Europe 14%, and in Asia Pacific 9%, with the overall foreign currency movements contributing a 3 percentage point favorable impact[182]. - Strong revenue growth was observed in the pharmaceutical, chemicals and advanced materials, food, academia and government, and diagnostics and clinical markets, with moderate growth in environmental and forensics markets[183]. Income and Expenses - Net income for the three months ended January 31, 2026, was $305 million, down from $318 million in the same period last year[136]. - Cash provided by operations was $268 million for the three months ended January 31, 2026, compared to $431 million in the same period last year[136]. - Total gross margin for the three months ended January 31, 2026, decreased to 52.6%, down 1 percentage point from 53.5% in the prior year[157]. - Research and development expenses increased by 4% to $117 million, driven by wage increases and higher variable pay[158]. - Selling, general and administrative expenses rose by 16% to $476 million, primarily due to higher corporate infrastructure expenses and restructuring costs[159]. - Operating margin decreased to 19.7%, down 3 percentage points from 22.4% in the previous year, impacted by higher tariffs and corporate infrastructure expenses[160]. - Income from operations decreased by $23 million or 6% to $353 million, despite a revenue increase of $117 million[160]. Cash Flow and Financing - The company paid cash dividends of $0.255 per common share, totaling approximately $72 million during the three months ended January 31, 2026[137]. - Net cash provided by operating activities was $268 million, down from $431 million in the same period last year, with significant increases in variable and incentive pay[201]. - Net cash used in financing activities for the three months ended January 31, 2026 was $222 million, an increase from $180 million in the same period of 2025[206]. - The company repurchased and retired 1.050 million shares for $152 million during the three months ended January 31, 2026, with remaining authorization to repurchase approximately $1,797 million under the 2024 repurchase program[207]. - The company had no borrowings or repayments under its $1.5 billion unsecured credit facility and $750 million incremental revolving credit facility as of January 31, 2026[210]. - Under the U.S. commercial paper program, the company borrowed and repaid $225 million during the three months ended January 31, 2026, compared to $301 million borrowed and $331 million repaid in the same period of 2025[213]. Future Outlook and Strategic Initiatives - The restructuring plan is expected to result in annual cost savings of approximately $90 million to $95 million across all business segments[146]. - The company anticipates fully offsetting the impact of tariff changes on revenue during fiscal year 2026 through various mitigation strategies[141]. - The company remains optimistic about long-term growth in its end markets and plans to continue investing in research and development and expanding its applications and solutions portfolio[174]. - Total capital expenditures for the current year are expected to be approximately $500 million, primarily for expanding manufacturing capacity in Frederick, Colorado[205]. Currency Impact - The overall effect of foreign currency movements had a 3 percentage point favorable impact on revenue growth for the three months ended January 31, 2026[135]. - Changes in foreign currency exchange rates had a 3 percentage point favorable impact on revenue growth for the three months ended January 31, 2026[220]. - A hypothetical 10 percent adverse movement in foreign exchange rates would not have a material effect on the company's financial position as of January 31, 2026[221]. - The company performed a sensitivity analysis indicating that a hypothetical 10 percent adverse movement in interest rates would result in an immaterial impact on the fair value of fixed interest rate debt[223].